Skip to main content
Journal cover image

Circulating Th1/17 cells serve as a biomarker of disease severity and a target for early intervention in AChR-MG patients

Publication ,  Journal Article
Ma, Q; Ran, H; Li, Y; Lu, Y; Liu, X; Huang, H; Yang, W; Yu, L; Chen, P; Huang, X; Qiu, L; Lin, Z; Ou, C; Liu, W
Published in: Clinical Immunology
September 2020

Duke Scholars

Published In

Clinical Immunology

DOI

ISSN

1521-6616

Publication Date

September 2020

Volume

218

Start / End Page

108492 / 108492

Publisher

Elsevier BV

Related Subject Headings

  • Immunology
  • 3204 Immunology
  • 1107 Immunology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ma, Q., Ran, H., Li, Y., Lu, Y., Liu, X., Huang, H., … Liu, W. (2020). Circulating Th1/17 cells serve as a biomarker of disease severity and a target for early intervention in AChR-MG patients. Clinical Immunology, 218, 108492–108492. https://doi.org/10.1016/j.clim.2020.108492
Ma, Qian, Hao Ran, Yingkai Li, Yaru Lu, Xiaoxi Liu, Huan Huang, Wenhao Yang, et al. “Circulating Th1/17 cells serve as a biomarker of disease severity and a target for early intervention in AChR-MG patients.” Clinical Immunology 218 (September 2020): 108492–108492. https://doi.org/10.1016/j.clim.2020.108492.
Ma Q, Ran H, Li Y, Lu Y, Liu X, Huang H, et al. Circulating Th1/17 cells serve as a biomarker of disease severity and a target for early intervention in AChR-MG patients. Clinical Immunology. 2020 Sep;218:108492–108492.
Ma, Qian, et al. “Circulating Th1/17 cells serve as a biomarker of disease severity and a target for early intervention in AChR-MG patients.” Clinical Immunology, vol. 218, Elsevier BV, Sept. 2020, pp. 108492–108492. Crossref, doi:10.1016/j.clim.2020.108492.
Ma Q, Ran H, Li Y, Lu Y, Liu X, Huang H, Yang W, Yu L, Chen P, Huang X, Qiu L, Lin Z, Ou C, Liu W. Circulating Th1/17 cells serve as a biomarker of disease severity and a target for early intervention in AChR-MG patients. Clinical Immunology. Elsevier BV; 2020 Sep;218:108492–108492.
Journal cover image

Published In

Clinical Immunology

DOI

ISSN

1521-6616

Publication Date

September 2020

Volume

218

Start / End Page

108492 / 108492

Publisher

Elsevier BV

Related Subject Headings

  • Immunology
  • 3204 Immunology
  • 1107 Immunology